We are thrilled to announce that Ego Pharmaceuticals has been named on the Australian Financial Review (AFR) Sustainability Leaders List for 2025, in the Manufacturing and Consumer Goods category. This prestigious list celebrates Australasian companies actively addressing sustainability challenges while simultaneously generating business value.

Our inclusion on this list is a direct result of Ego's unwavering commitment to sustainability, spearheaded by our dedicated, cross-functional Sustainability Committee. This committee, comprised of staff from various departments, works collaboratively to drive meaningful change, reducing our environmental footprint and embedding a sustainability-first mindset throughout the entire Ego business.

Ego's inclusion on this year's list is a direct result of our comprehensive commitment to reducing environmental impact. This is demonstrated through initiatives that drive down CO2 emissions, energy usage, waste, and water consumption, further bolstered by our integration of technology to enhance efficiency and accelerate sustainability. Beyond environmental stewardship, Ego was also recognised for our dedication to people and community, exemplified by our impactful partnership with Good360, which facilitates product donations to those in need instead of contributing to landfill, and our robust Modern Slavery Policy.

This recognition is a testament to not only the hard work of the Sustainability Committee members but also to all of Ego's people who play a vital role in helping us make progress towards our sustainability goals and reduce our impact on the planet. We believe that by embedding sustainability into our core operations, we not only contribute to a better tomorrow but also gain significant business benefits, including operational cost savings and enhanced brand loyalty.

We are incredibly proud to be acknowledged as a leader in sustainability and remain committed to continuous innovation and improvement in our journey towards a more sustainable future.